Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17199224rdf:typepubmed:Citationlld:pubmed
pubmed-article:17199224lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C0025885lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C0285890lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:17199224lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:17199224pubmed:issue1lld:pubmed
pubmed-article:17199224pubmed:dateCreated2007-1-2lld:pubmed
pubmed-article:17199224pubmed:abstractTextParkinson disease (PD) is the second most common neurodegenerative disease of adult onset. Is a progressive movement disorder including tremor, bradykinesia, rigidity and postural instability, with an age onset between 43 and 66 years. Histopathologically, is characterized by a severe loss of dopaminergic neurons in the substantia nigra and inclusions consisting of insoluble protein aggregates called Lewy bodies, this are comprised in part of alpha-synuclein. The etiology of PD is still not fully understood, but genetic analyses, epidemiologic studies and experimental models of PD are providing important new insights into the pathogenesis of PD.lld:pubmed
pubmed-article:17199224pubmed:languagespalld:pubmed
pubmed-article:17199224pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17199224pubmed:citationSubsetIMlld:pubmed
pubmed-article:17199224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17199224pubmed:statusMEDLINElld:pubmed
pubmed-article:17199224pubmed:issn0210-0010lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Gallegos-Arre...lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Jiménez-GilF...lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Ruiz-Sandoval...lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Ramírez-Jiran...lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Ramírez-VegaJ...lld:pubmed
pubmed-article:17199224pubmed:authorpubmed-author:Vargas-Frutos...lld:pubmed
pubmed-article:17199224pubmed:issnTypePrintlld:pubmed
pubmed-article:17199224pubmed:volume44lld:pubmed
pubmed-article:17199224pubmed:ownerNLMlld:pubmed
pubmed-article:17199224pubmed:authorsCompleteYlld:pubmed
pubmed-article:17199224pubmed:pagination15-7lld:pubmed
pubmed-article:17199224pubmed:dateRevised2009-5-28lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:meshHeadingpubmed-meshheading:17199224...lld:pubmed
pubmed-article:17199224pubmed:articleTitle[Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].lld:pubmed
pubmed-article:17199224pubmed:affiliationLaboratorio de Genética Molecular, División de Medicina Molecular, CIBO-IMSS, Jalisco, México.lld:pubmed
pubmed-article:17199224pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17199224pubmed:publicationTypeEnglish Abstractlld:pubmed
entrez-gene:6622entrezgene:pubmedpubmed-article:17199224lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17199224lld:entrezgene